Solazyme files for IPO

March 29, 2011 | Analyst Insight

Predictably, Solazyme has filed for an initial public offering (IPO), targeting $100 million. Why was it predictable? Because just as Amyris bolstered its business with multiple strong partnerships in the months...

Related companies	Honeywell, DowDuPont, DSM, Algenol, Solazyme, Chevron, Amyris, Gevo, Phycal, Parabel, Martek Biosciences, Roquette, Bunge Limited, Ecopetrol, Abengoa

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978